Photodynamic therapy for oral candidiasis in human clinical trials: an evidence-based analysis

Yao Lin1, Jianfeng Ding2, Yufu He1

  • 1Jieyang Medical Research Center, Jieyang People's Hospital (Jieyang Affiliated Hospital of Sun Yat-sen University), Jieyang, Guangdong, China.

Abstract

Insights

Photodynamic therapy (PDT) shows similar effectiveness to antifungal drug treatment (AT) for oral candidiasis. Combining PDT with AT significantly enhances cure rates and reduces Candida counts, offering a promising alternative therapy.

Area of Science:

  • Oral medicine
  • Antimicrobial therapies
  • Photodynamic therapy

Background:

  • Traditional antifungal drug treatment (AT) for oral candidiasis can lead to drug resistance.
  • Developing alternative and effective treatments for oral candidiasis is crucial.

Purpose of the Study:

  • To compare the efficacy of photodynamic therapy (PDT) versus AT in managing oral candidiasis.
  • To evaluate the impact of PDT, AT, and their combination on Candida colony counts and clinical outcomes.

Main Methods:

  • A systematic review and network meta-analysis of 16 clinical trials, including 13 RCTs, were conducted.
  • Searched Cochrane Library, Web of Science, and PubMed databases up to June 25, 2024.
  • Outcomes assessed included clinical response and changes in Candida colony counts.

Main Results:

  • PDT and AT demonstrated comparable overall response rates for oral candidiasis.
  • Combination therapy (PDT+AT) showed a significantly higher cure rate than AT alone.
  • PDT+AT was most effective in reducing Candida colony counts, followed by AT, PDT, chlorhexidine, and distilled water.

Conclusions:

  • PDT is a viable alternative to AT for oral candidiasis treatment.
  • Combining PDT with AT enhances therapeutic outcomes and Candida reduction.
  • Further large-scale, high-quality RCTs are recommended to validate these findings.